EUR 13.5
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 924.06 Million EUR | 3.84% |
2022 | 889.91 Million EUR | 11.58% |
2021 | 797.58 Million EUR | -11.9% |
2020 | 905.35 Million EUR | 11.96% |
2019 | 808.61 Million EUR | 24.77% |
2018 | 648.1 Million EUR | -13.15% |
2017 | 746.22 Million EUR | 5.24% |
2016 | 709.08 Million EUR | -17.96% |
2015 | 864.28 Million EUR | -24.79% |
2014 | 1.14 Billion EUR | -5.89% |
2013 | 1.22 Billion EUR | -5.21% |
2012 | 1.28 Billion EUR | -7.54% |
2011 | 1.39 Billion EUR | 1.18% |
2010 | 1.37 Billion EUR | 3.66% |
2009 | 1.32 Billion EUR | 2.45% |
2008 | 1.29 Billion EUR | 3.75% |
2007 | 1.24 Billion EUR | 101.75% |
2006 | 619.43 Million EUR | 79.65% |
2005 | 344.8 Million EUR | -23.41% |
2004 | 450.18 Million EUR | 28.28% |
2003 | 350.95 Million EUR | 17.69% |
2002 | 298.2 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 983.65 Million EUR | 0.0% |
2024 Q1 | 983.65 Million EUR | 6.45% |
2023 FY | 924.06 Million EUR | 3.84% |
2023 Q2 | 900.06 Million EUR | 0.0% |
2023 Q3 | 924.06 Million EUR | 2.67% |
2023 Q1 | 900.06 Million EUR | 1.14% |
2023 Q4 | 924.06 Million EUR | 0.0% |
2022 Q4 | 889.91 Million EUR | 0.0% |
2022 FY | 889.91 Million EUR | 11.58% |
2022 Q1 | 859.92 Million EUR | 7.82% |
2022 Q2 | 859.92 Million EUR | -0.0% |
2022 Q3 | 889.91 Million EUR | 3.49% |
2021 Q1 | 797.43 Million EUR | -11.92% |
2021 Q2 | 797.43 Million EUR | 0.0% |
2021 FY | 797.58 Million EUR | -11.9% |
2021 Q4 | 797.58 Million EUR | 0.0% |
2021 Q3 | 797.58 Million EUR | 0.02% |
2020 Q4 | 905.35 Million EUR | 0.0% |
2020 Q1 | 870.02 Million EUR | 7.59% |
2020 Q2 | 870.02 Million EUR | 0.0% |
2020 Q3 | 905.35 Million EUR | 4.06% |
2020 FY | 905.35 Million EUR | 11.96% |
2019 Q2 | 745.64 Million EUR | 0.0% |
2019 FY | 808.61 Million EUR | 24.77% |
2019 Q4 | 808.61 Million EUR | 0.0% |
2019 Q3 | 808.61 Million EUR | 8.45% |
2019 Q1 | 745.64 Million EUR | 15.05% |
2018 FY | 648.1 Million EUR | -13.15% |
2018 Q4 | 648.1 Million EUR | -0.0% |
2018 Q3 | 648.1 Million EUR | 9.2% |
2018 Q2 | 593.51 Million EUR | 0.0% |
2018 Q1 | 593.51 Million EUR | -20.46% |
2017 FY | 746.22 Million EUR | 5.24% |
2017 Q4 | 746.22 Million EUR | 0.0% |
2017 Q3 | 746.22 Million EUR | 6.28% |
2017 Q2 | 702.14 Million EUR | 0.0% |
2017 Q1 | 702.14 Million EUR | -0.98% |
2016 Q2 | 666.27 Million EUR | -0.06% |
2016 FY | 709.08 Million EUR | -17.96% |
2016 Q3 | 659.92 Million EUR | -0.95% |
2016 Q4 | 709.08 Million EUR | 7.45% |
2016 Q1 | 666.68 Million EUR | -22.86% |
2015 Q3 | 783.79 Million EUR | -10.26% |
2015 FY | 864.28 Million EUR | -24.79% |
2015 Q4 | 864.28 Million EUR | 10.27% |
2015 Q2 | 873.4 Million EUR | -30.12% |
2015 Q1 | 1.24 Billion EUR | 8.75% |
2014 Q3 | 1.26 Billion EUR | 2.41% |
2014 FY | 1.14 Billion EUR | -5.89% |
2014 Q1 | 1.19 Billion EUR | -2.37% |
2014 Q2 | 1.23 Billion EUR | 3.83% |
2014 Q4 | 1.14 Billion EUR | -9.34% |
2013 Q4 | 1.22 Billion EUR | -5.74% |
2013 FY | 1.22 Billion EUR | -5.21% |
2013 Q2 | 1.31 Billion EUR | 0.94% |
2013 Q1 | 1.3 Billion EUR | 1.0% |
2013 Q3 | 1.29 Billion EUR | -1.36% |
2012 FY | 1.28 Billion EUR | -7.54% |
2012 Q2 | 1.27 Billion EUR | 0.0% |
2012 Q4 | 1.28 Billion EUR | 0.0% |
2011 Q2 | 1.33 Billion EUR | 0.0% |
2011 Q4 | 1.39 Billion EUR | 0.0% |
2011 FY | 1.39 Billion EUR | 1.18% |
2010 Q4 | 1.37 Billion EUR | 0.0% |
2010 Q2 | 1.53 Billion EUR | 0.0% |
2010 FY | 1.37 Billion EUR | 3.66% |
2009 FY | 1.32 Billion EUR | 2.45% |
2009 Q4 | 1.32 Billion EUR | 0.0% |
2008 FY | 1.29 Billion EUR | 3.75% |
2007 FY | 1.24 Billion EUR | 101.75% |
2006 FY | 619.43 Million EUR | 79.65% |
2005 FY | 344.8 Million EUR | -23.41% |
2004 FY | 450.18 Million EUR | 28.28% |
2003 FY | 350.95 Million EUR | 17.69% |
2002 FY | 298.2 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Guerbet SA | 1.02 Billion EUR | 9.868% |
Nexus AG | 411.71 Million EUR | -124.443% |
Bastide Le Confort Médical SA | 647.06 Million EUR | -42.809% |
Revenio Group Oyj | 137.4 Million EUR | -572.539% |
Drägerwerk AG & Co. KGaA | 3.25 Billion EUR | 71.623% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 90.528% |
LNA Santé SA | 1.5 Billion EUR | 38.687% |
Siemens Healthineers AG | 46.68 Billion EUR | 98.021% |
Medios AG | 594.75 Million EUR | -55.37% |
Equasens Société anonyme | 394.04 Million EUR | -134.508% |
Stratec SE | 479.53 Million EUR | -92.702% |